Patent ID: 11957745
Assignee: VANDERBILT UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G  Y | IPC A  C  G

Claim 17:
18. The method of claim 17, further comprising:
(c) contacting a sample comprising said antigen with an antibody or antigen-binding fragment thereof having having heavy and light chain CDR1-3 sequences comprising SEQ ID NOS: 17-19 and 29-31, SEQ ID NOS: 26-28 and 38-40, SEQ ID NOS: 20-22 and 32-34 or SEQ ID NOS: 23-25 and 35-37, respectively; and
(d) determining stability over time of said antigen by detectable binding of said antibody or antigen-binding fragment thereof to said antigen.